Company Filing History:
Years Active: 2025
Title: Berna Dogan: Innovator in Therapeutic Compounds
Introduction
Berna Dogan is a prominent inventor based in Besiktas, Istanbul, Turkey. He has made significant contributions to the field of therapeutic compounds, particularly in the development of BCL-2 inhibitors. With a total of 5 patents to his name, Dogan is recognized for his innovative approach to drug discovery.
Latest Patents
Dogan's latest patents focus on the physics-driven discovery of novel small therapeutic compounds for use as BCL-2 inhibitors. The invention relates to a compound shown with formula (I) or a pharmaceutically acceptable derivative thereof, which serves as a novel inhibitor of BCL-2. This groundbreaking work has the potential to impact cancer treatment significantly.
Career Highlights
Currently, Berna Dogan is affiliated with Bahçesehir Üniversitesi, where he continues to advance his research in therapeutic compounds. His work has garnered attention in the scientific community, contributing to the understanding of BCL-2 inhibitors and their applications in medicine.
Collaborations
Dogan collaborates with talented individuals such as Muge Didem Orhan and Seyma Calis, enhancing the research environment and fostering innovation in his field.
Conclusion
Berna Dogan's contributions to the development of therapeutic compounds highlight his role as a leading inventor in the medical field. His innovative work on BCL-2 inhibitors showcases the potential for advancements in cancer treatment.